Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$12.42 - $17.29 $155,250 - $216,125
12,500 New
12,500 $195,000
Q1 2023

May 05, 2023

BUY
$56.44 - $118.81 $657,356 - $1.38 Million
11,647 New
11,647 $700,000
Q3 2022

Oct 25, 2022

SELL
$67.99 - $89.57 $663,242 - $873,755
-9,755 Reduced 47.51%
10,776 $819,000
Q2 2022

Jul 27, 2022

BUY
$56.6 - $89.9 $1.16 Million - $1.85 Million
20,531 New
20,531 $1.43 Million

Others Institutions Holding NVCR

About NovoCure Ltd


  • Ticker NVCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 104,950,000
  • Market Cap $2.48B
  • Description
  • NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...
More about NVCR
Track This Portfolio

Track Versor Investments LP Portfolio

Follow Versor Investments LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Versor Investments LP, based on Form 13F filings with the SEC.

News

Stay updated on Versor Investments LP with notifications on news.